The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine

• Status: Withdrawn
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effects of triptans and doxycycline on neuroinflammatory markers in acute migraine.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The Cleveland Clinic
• Treatments: Doxycycline

Criteria

Inclusion Criteria:

• Clinical diagnosis of migraine with or without aura that fulfill the 2nd Edition of The International Headache Classification (ICHD-II) criteria

• Active prescription for an oral triptan medication to abort acute migraines

Exclusion Criteria:

• Tetracycline group or other anti-inflammatory medication use in the preceding three months

• Pregnant